ONCR || GI: Liver

VIDEO: Nivolumab puts brakes on advanced liver cancer

Posted on: 30/05/2015 - 15:44

CHICAGO – Immune checkpoint inhibition with nivolumab every 2 weeks provides a better response than does standard treatment for advanced liver cancer, phase I/II results suggest. The overall...

Field of Interest: Oncology

Type: News Item

Study outlines risk factors for solid organ cancers after liver transplantation

Posted on: 26/08/2014 - 20:05

SAN FRANCISCO – The indication for liver transplant, the selection of immunosuppression therapy, and smoking status influence the long-term risk of new solid organ malignancies after liver...

Field of Interest: Gastroentero...

Type: News Item

Statins associated with significant decrease in risk of hepatocellular carcinoma

Posted on: 25/08/2014 - 20:00

Use of statins for any duration of time is associated with a significant reduction in the risk of hepatocellular carcinoma in low-risk populations. A nested case-control study among 94 cases of...

Field of Interest: Oncology

Type: News Item

Liver cancer without cirrhosis surprisingly common: Is NAFLD the cause?

Posted on: 30/05/2014 - 17:15

CHICAGO – A full 13% of patients diagnosed with hepatocellular carcinoma did not have underlying cirrhosis in a national sample of 1,500 veterans. Although hepatocellular carcinoma (HCC) in patients...

Field of Interest: Gastroentero...

Type: News Item

Liver cancer without cirrhosis surprisingly common: Is NAFLD the cause?

Posted on: 30/05/2014 - 17:15

Field of Interest: Oncology

Type: News Item

Expanded cytoreduction criteria improved survival of carcinoid liver metastases

Posted on: 07/05/2014 - 18:20

BOSTON – Relaxing eligibility criteria for cytoreductive surgery may improve overall survival among patients with carcinoid metastases to the liver, investigators report. Lowering the debulking...

Field of Interest: Oncology

Type: News Item

Expanded cytoreduction criteria improved survival of carcinoid liver metastases

Posted on: 07/05/2014 - 18:20

BOSTON – Relaxing eligibility criteria for cytoreductive surgery may improve overall survival among patients with carcinoid metastases to the liver, investigators report. Lowering the debulking...

Field of Interest: Gastroentero...

Type: News Item

Hepatitis C drugs pricey, but cure is priceless

Posted on: 28/04/2014 - 18:05

It was almost as if someone decided April would be hepatitis C month. In case you hadn’t notice, April saw publication of six separate articles in the New England Journal of Medicine on what were...

Field of Interest: Infectious diseases

Type: News Item

Hepatitis C drugs pricey, but cure is priceless

Posted on: 28/04/2014 - 18:05

Field of Interest: Gastroentero...

Type: News Item

Herbal medicines and supplements carry risk of hepatoxicity

Posted on: 23/04/2014 - 18:14

LONDON – Herbal medicines and other home remedies or supplements are a significant cause of hepatotoxicity experts warned recently during a symposium at the International Liver Congress, which...

Field of Interest: Gastroentero...

Type: News Item

VIDEO: Nivolumab puts brakes on advanced liver cancer

Study outlines risk factors for solid organ cancers after liver transplantation

Statins associated with significant decrease in risk of hepatocellular carcinoma

Liver cancer without cirrhosis surprisingly common: Is NAFLD the cause?

Liver cancer without cirrhosis surprisingly common: Is NAFLD the cause?

Expanded cytoreduction criteria improved survival of carcinoid liver metastases

Expanded cytoreduction criteria improved survival of carcinoid liver metastases

Hepatitis C drugs pricey, but cure is priceless

Hepatitis C drugs pricey, but cure is priceless

Herbal medicines and supplements carry risk of hepatoxicity

Newsletters

Latest Newsletters

You are here

ONCR || GI: Liver

Newsletters

Latest Newsletters